Synercid (quinupristin-dalfopristin) is now available for emergency use

Rhone-Poulenc Rorer's investigational antibiotic Synercid (quinupristin-dalfopristin) is now available for emergency use...for certain resistant Gram-positive infections.

It's being used for vancomycin-resistant enterococci (VRE)...and methicillin-resistant Staph aureus (MRSA) or Staph epidermidis in patients who can't take vancomycin. It also seems to be active against penicillin-resistant pneumococcus.

Both quinupristin and dalfopristin are in a new class of antibiotics called streptogramins. The combination has synergistic effects. (Hence the name Synercid.)

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote